JENELLE TORRES: Open Payments
NPI 1912474958 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$348 in 17 payments from 12 companies in 2025. Trend: 2023 $13 · 2024 $507 · 2025 $348
Food & beverage: $348
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $84 |
| PFIZER INC. | 2 | $41 |
| Amgen Inc. | 2 | $35 |
| Astellas Pharma US Inc | 1 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Amphastar Pharmaceuticals, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| ABIOMED | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
Products named: FREESTYLE LIBRE 3, Veozah, GEMTESA, ELIQUIS, SHINGRIX, VYNDAMAX, JARDIANCE, EVENITY.
Industry payments across FL — which companies pay providers there.
